Evaluating a marker's contribution to a nomogram: the GEMCaP example.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 20028766.
- Also identified by DOI 10.1158/1078-0432.CCR-09-2946.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A postoperative nomogram developed in 1999 by Kattan et al. has been externally validated, but needs improvement. This tool predicts well but not perfectly. The Genomic Evaluators of Metastatic Prostate Cancer (GEMCaP) biomarkers hold promise for improving this tool; however, a larger data set that permits more involved analyses is needed.
Medical subject headings
- Biomarkers, Tumor
- Models, Statistical
- Nomograms
- Prostatic Neoplasms